Allianz Asset Management
ARIA

Allianz Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Allianz Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-188,821
Closed -$2.58M – 2741
2016
Q3 		$2.58M Buy
188,821
+40,100
+27% +$403K ﹤0.01% 1893
2016
Q2 		$1.1M Buy
+148,721
New +$1.12M ﹤0.01% 2147
2014
Q2 		– Sell
-349,200
Closed -$2.81M – 2041
2014
Q1 		$2.81M Sell
349,200
-209,000
-37% -$1.63M ﹤0.01% 1106
2013
Q4 		$3.81M Sell
558,200
-1,113,500
-67% -$6.01M ﹤0.01% 1027
2013
Q3 		$30.8M Buy
1,671,700
+1,547,300
+1,244% +$30M 0.04% 437
2013
Q2 		$2.18M Buy
+124,400
New +$2.21M ﹤0.01% 1182

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Allianz Asset Management's ARIA Position: Q4 2016 in Review

Allianz Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2016, closing a stake of 188,821 shares — an estimated $2.58M sold.

Allianz Asset Management first reported a position in ARIA in Q2 2013 and held it in 6 quarters. The position peaked at $30.8M in Q3 2013. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

  • Allianz Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • Allianz Asset Management sold 188,821 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $2.58M.
  • Allianz Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 6 quarters.
  • Allianz Asset Management's Ariad Pharmaceuticals Inc position peaked at $30.8M in Q3 2013.
  • 200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on Allianz Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.